According to reports, patients with tumors with high expression of ENO1 have a poor prognosis, including NSCLC [14, 18], breast cancer [19], glioma [7], bladder cancer [9], pancreatic cancer [20], liver cancer [21], and gastric cancer [21]. This evidence concerns the gene ENO1 and gastric cancer.